Abgenix clinical trials
Acquired by Amgen, Apr 3, 2006 · source ↗
The registry lists 3 studies whose lead sponsor is Abgenix. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 24, 2005.
Before and after it joined Amgen
- First submitted before Abgenix became part of Amgen
- 3
- First submitted after Abgenix became part of Amgen
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Abgenix3 studies
Something wrong with this grouping? Tell us on the Amgen page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Amgen studies →
- Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host DiseaseCompletedNCT00035880Phase 2/3
Sponsor listed in the registry: Abgenix · First submitted before Abgenix became part of Amgen
- ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the BodyCompletedNCT00061126Phase 2
Sponsor listed in the registry: Abgenix · First submitted before Abgenix became part of Amgen
- A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPDCompletedNCT00035828Phase 2
Sponsor listed in the registry: Abgenix · First submitted before Abgenix became part of Amgen